降糖药-话题@MedSci

#降糖药#

178篇内容 | 4706人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1270936, encodeId=a29112e0936cb, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=JAMA Netw Open：2型糖尿病和动脉粥样硬化性心血管疾病患者使用降脂、降压和降糖药物治疗, objectType=article, longId=299258, objectId=9c012992583a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c012992583a, replyNumber=0, likeNumber=72, createdTime=2022-02-22, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c012992583a, moduleTitle=JAMA Netw Open：2型糖尿病和动脉粥样硬化性心血管疾病患者使用降脂、降压和降糖药物治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c012992583a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270935, encodeId=041112e093529, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=JAMA：礼来新型降糖药tirzepatide可以显著改善糖尿病血糖和体重水平, objectType=article, longId=295349, objectId=32ce295349f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32ce295349f4, replyNumber=0, likeNumber=83, createdTime=2022-02-11, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32ce295349f4, moduleTitle=JAMA：礼来新型降糖药tirzepatide可以显著改善糖尿病血糖和体重水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32ce295349f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270934, encodeId=ea4112e093491, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=CKD患者注射降糖药物的剂量调整有大学问！一起来围观吧！, objectType=article, longId=221283, objectId=a42f22128349, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a42f22128349, replyNumber=0, likeNumber=84, createdTime=2021-12-01, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a42f22128349, moduleTitle=CKD患者注射降糖药物的剂量调整有大学问！一起来围观吧！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a42f22128349)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270933, encodeId=85c812e0933ec, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Hepatology：降糖药和血糖控制情况对非酒精性脂肪肝患者肝癌风险的影响, objectType=article, longId=220537, objectId=6cb822053e10, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cb822053e10, replyNumber=0, likeNumber=70, createdTime=2021-11-19, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cb822053e10, moduleTitle=Hepatology：降糖药和血糖控制情况对非酒精性脂肪肝患者肝癌风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cb822053e10)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270932, encodeId=47a312e09324a, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Diabetes Obes Metab：利拉鲁肽与口服降糖药作为附加疗法在单独使用二甲双胍的2型糖尿病患者中维持血糖控制, objectType=article, longId=220270, objectId=1e7d2202e0c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e7d2202e0c3, replyNumber=0, likeNumber=123, createdTime=2021-11-15, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e7d2202e0c3, moduleTitle=Diabetes Obes Metab：利拉鲁肽与口服降糖药作为附加疗法在单独使用二甲双胍的2型糖尿病患者中维持血糖控制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e7d2202e0c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270948, encodeId=a69712e0948c2, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Diabetologia：糖尿病患者降糖药物使用与新发房颤的关系, objectType=article, longId=219959, objectId=3e8421995953, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e8421995953, replyNumber=0, likeNumber=107, createdTime=2021-11-09, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e8421995953, moduleTitle=Diabetologia：糖尿病患者降糖药物使用与新发房颤的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e8421995953)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270931, encodeId=e05a12e0931ca, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Lancet子刊：新型降糖药SGLT2抑制剂达格列净能明显保护糖尿病肾病！, objectType=article, longId=218938, objectId=389521893854, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=389521893854, replyNumber=0, likeNumber=86, createdTime=2021-10-22, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=389521893854, moduleTitle=Lancet子刊：新型降糖药SGLT2抑制剂达格列净能明显保护糖尿病肾病！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=389521893854)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270930, encodeId=f87512e09305c, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Diabetologia ：新型降糖药物对心血管结局的有效性和安全性, objectType=article, longId=218506, objectId=3ac8218506b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ac8218506b2, replyNumber=0, likeNumber=104, createdTime=2021-10-14, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ac8218506b2, moduleTitle=Diabetologia ：新型降糖药物对心血管结局的有效性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ac8218506b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270929, encodeId=ec5412e0929c6, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Lancet：2型糖尿病治疗，礼来tirzepatide临床击败“网红降糖药”索马鲁肽！, objectType=article, longId=215739, objectId=085d215e399a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=085d215e399a, replyNumber=0, likeNumber=90, createdTime=2021-08-16, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=085d215e399a, moduleTitle=Lancet：2型糖尿病治疗，礼来tirzepatide临床击败“网红降糖药”索马鲁肽！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=085d215e399a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270928, encodeId=41ac12e092867, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=降糖药SGLT-2抑制剂也能治心衰？看完本文马上掌握！, objectType=article, longId=214626, objectId=4e1d214626dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e1d214626dd, replyNumber=0, likeNumber=76, createdTime=2021-07-24, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e1d214626dd, moduleTitle=降糖药SGLT-2抑制剂也能治心衰？看完本文马上掌握！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e1d214626dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270927, encodeId=f9d012e09271c, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=JCEM：降糖药与心衰住院的关系, objectType=article, longId=213629, objectId=6d2821362930, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d2821362930, replyNumber=0, likeNumber=66, createdTime=2021-07-03, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d2821362930, moduleTitle=JCEM：降糖药与心衰住院的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d2821362930)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270926, encodeId=3fb512e092661, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Lancet Diabetes Endo：降糖药物处方对糖尿病患者新冠肺炎死亡风险的影响, objectType=article, longId=210098, objectId=17032100981e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17032100981e, replyNumber=0, likeNumber=90, createdTime=2021-04-19, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17032100981e, moduleTitle=Lancet Diabetes Endo：降糖药物处方对糖尿病患者新冠肺炎死亡风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17032100981e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270925, encodeId=096112e092574, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Diabetes Care：新型降糖药依米格列酮有效改善2型糖尿病患者HbA1c, objectType=article, longId=209577, objectId=1c842095e7dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c842095e7dd, replyNumber=0, likeNumber=80, createdTime=2021-04-06, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c842095e7dd, moduleTitle=Diabetes Care：新型降糖药依米格列酮有效改善2型糖尿病患者HbA1c, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c842095e7dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270924, encodeId=e94b12e092410, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Diabetes Care：新型降糖药可有效改善亚洲人心血管风险, objectType=article, longId=209571, objectId=ac072095e116, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac072095e116, replyNumber=0, likeNumber=61, createdTime=2021-04-06, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac072095e116, moduleTitle=Diabetes Care：新型降糖药可有效改善亚洲人心血管风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac072095e116)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270923, encodeId=bf1e12e092332, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=格列齐特缓释片在2型糖尿病中的地位：与其他磺酰脲类药物和新型口服降糖药的比较, objectType=article, longId=206233, objectId=353b20623324, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=353b20623324, replyNumber=0, likeNumber=40, createdTime=2021-01-27, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=353b20623324, moduleTitle=格列齐特缓释片在2型糖尿病中的地位：与其他磺酰脲类药物和新型口服降糖药的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=353b20623324)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270922, encodeId=41f512e09227b, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Diabetes Care：您有新的短信提醒该吃降糖药了…这块蛋糕不能吃…, objectType=article, longId=203290, objectId=5c3520329068, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c3520329068, replyNumber=0, likeNumber=57, createdTime=2020-11-14, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c3520329068, moduleTitle=Diabetes Care：您有新的短信提醒该吃降糖药了…这块蛋糕不能吃…, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c3520329068)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270921, encodeId=00d012e0921ae, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=中国心血管病患者达3.3亿 | 新型降糖药对慢性肾病合并糖尿病患者的心血管保护作用, objectType=article, longId=201384, objectId=28d9201384e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28d9201384e3, replyNumber=0, likeNumber=106, createdTime=2020-10-01, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28d9201384e3, moduleTitle=中国心血管病患者达3.3亿 | 新型降糖药对慢性肾病合并糖尿病患者的心血管保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28d9201384e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270920, encodeId=f6c012e092036, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Diabetes Care：降糖药和抑郁症发病率的关系 , objectType=article, longId=201299, objectId=92b320129948, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92b320129948, replyNumber=0, likeNumber=95, createdTime=2020-09-29, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92b320129948, moduleTitle=Diabetes Care：降糖药和抑郁症发病率的关系 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92b320129948)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270919, encodeId=52a912e091901, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=心血管医师应倡导使用新型降糖药物！ACC更新决策路径, objectType=article, longId=198959, objectId=ec68198959d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec68198959d2, replyNumber=0, likeNumber=87, createdTime=2020-08-09, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec68198959d2, moduleTitle=心血管医师应倡导使用新型降糖药物！ACC更新决策路径, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec68198959d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270918, encodeId=5c5912e09185a, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=【Cell子刊】一种口服降糖药治疗糖尿病的效果优于二甲双胍和恩格列净！对30万种化合物高通量筛选得出！, objectType=article, longId=198777, objectId=56b4198e774b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56b4198e774b, replyNumber=0, likeNumber=82, createdTime=2020-08-07, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56b4198e774b, moduleTitle=【Cell子刊】一种口服降糖药治疗糖尿病的效果优于二甲双胍和恩格列净！对30万种化合物高通量筛选得出！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56b4198e774b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

降糖药

2020-05-29

hb2008ye (审核中...)

前往app查看评论内容

#降糖药#

JAMA Netw Open：2型糖尿病和动脉粥样硬化性心血管疾病患者使用降脂、降压和降糖药物治疗

2022-02-22

hb2008ye (审核中...)

前往app查看评论内容

#降糖药#

JAMA：礼来新型降糖药tirzepatide可以显著改善糖尿病血糖和体重水平

2022-02-11

hb2008ye (审核中...)

前往app查看评论内容

#降糖药#

CKD患者注射降糖药物的剂量调整有大学问！一起来围观吧！

2021-12-01

hb2008ye (审核中...)

前往app查看评论内容

#降糖药#

Hepatology：降糖药和血糖控制情况对非酒精性脂肪肝患者肝癌风险的影响

2021-11-19

hb2008ye (审核中...)

前往app查看评论内容

#降糖药#

Diabetes Obes Metab：利拉鲁肽与口服降糖药作为附加疗法在单独使用二甲双胍的2型糖尿病患者中维持血糖控制

2021-11-15

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Diabetologia：糖尿病患者降糖药物使用与新发房颤的关系

2021-11-09

hb2008ye (审核中...)

前往app查看评论内容

#降糖药#

Lancet子刊：新型降糖药SGLT2抑制剂达格列净能明显保护糖尿病肾病！

2021-10-22

hb2008ye (审核中...)

前往app查看评论内容

#降糖药#

Diabetologia ：新型降糖药物对心血管结局的有效性和安全性

2021-10-14

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Lancet：2型糖尿病治疗，礼来tirzepatide临床击败“网红降糖药”索马鲁肽！

2021-08-16

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

降糖药SGLT-2抑制剂也能治心衰？看完本文马上掌握！

2021-07-24

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

JCEM：降糖药与心衰住院的关系

2021-07-03

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Lancet Diabetes Endo：降糖药物处方对糖尿病患者新冠肺炎死亡风险的影响

2021-04-19

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Diabetes Care：新型降糖药依米格列酮有效改善2型糖尿病患者HbA1c

2021-04-06

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Diabetes Care：新型降糖药可有效改善亚洲人心血管风险

2021-04-06

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

格列齐特缓释片在2型糖尿病中的地位：与其他磺酰脲类药物和新型口服降糖药的比较

2021-01-27

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Diabetes Care：您有新的短信提醒该吃降糖药了…这块蛋糕不能吃…

2020-11-14

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

中国心血管病患者达3.3亿 | 新型降糖药对慢性肾病合并糖尿病患者的心血管保护作用

2020-10-01

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Diabetes Care：降糖药和抑郁症发病率的关系

2020-09-29

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

心血管医师应倡导使用新型降糖药物！ACC更新决策路径

2020-08-09

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

【Cell子刊】一种口服降糖药治疗糖尿病的效果优于二甲双胍和恩格列净！对30万种化合物高通量筛选得出！

2020-08-07

科室
- - 订阅+
  - 更多科室
工具
服务